Alkeuspharmaceuticals
Alkeus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies to preserve sight for patients with retinal diseases. Recently acquired by Tarsus Pharmaceuticals, Alkeus continues its research in disease areas such as geographic atrophy and other degenerative eye conditions, advancing clinical trials and scientific collaborations to bring novel treatments to market.
Alkeuspharmaceuticals is profiled on the APIs.io network. Tagged areas include Biotechnology, Pharmaceuticals, Retinal Disease, Clinical Trials, and VisionHealth.
Kin Score
Terms of Service 1
What its API terms permit and prohibit, quoted from its own page.
Alkeuspharmaceuticals
11 quoted statements, read from Alkeuspharmaceuticals's own page on 2026-11-09.
TERMSPrivacy & Data 1
Its role, the data it processes, retention and transfers, quoted from its own privacy page.
Alkeuspharmaceuticals
26 quoted statements, read from Alkeuspharmaceuticals's own page on 2026-11-09.
PRIVACYEligibility 1
Who may sign up and where, quoted from its own terms.
Alkeuspharmaceuticals
2 quoted statements, read from Alkeuspharmaceuticals's own page on 2026-11-09.
ELIGIBILITYAI Preferences 1
Its stance on AI training, inference and agents, quoted from its own pages.
Alkeuspharmaceuticals
1 quoted statement, read from Alkeuspharmaceuticals's own page on 2026-11-09.
AI PREFSSecurity Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Commercial 3
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API
Other 4
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.